New Key Statistics Module, Z-Score and F-Score
HKSE:01541 Key Ratios
Market Cap HK$ M | 5,462.70 |
Enterprise Value HK$ M | 4,876.26 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 6.67 |
Price/Sales | 14,600.00 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) HK$ M | -- |
EPS (TTM) HK$ | -1.15 |
Beneish M-Score | -2.74 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -11.43 |
EV-to-EBITDA | -12.16 |
PEG | -- |
Shares Outstanding M | 374.16 |
Net Margin (%) | -98,351.90 |
Operating Margin % | -94,519.43 |
Pre-tax Margin (%) | -98,351.90 |
Quick Ratio | 5.92 |
Current Ratio | 5.92 |
ROA % (ttm) | -46.22 |
ROE % (ttm) | -51.89 |
ROIC % (ttm) | -141.56 |
Dividend Yield % | -- |
Altman Z-Score | 21.78 |
HKSE:01541 Number of Guru Trades
HKSE:01541 Volume of Guru Trades
Gurus Latest Trades with HKSE:01541
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:01541 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Insider Transactions
No Available Data